可激活磁共振成像纳米探针的制备及生物医学应用

在生物医学领域,磁共振成像是一种非常重要的疾病诊疗技术.近50%的磁共振检查已经涉及造影剂的应用.可激活磁共振成像纳米探针以优化信噪比为原则,借助特异性的生物分子识别作用或分子交互作用增强磁共振信号,提高了磁共振诊断的敏感性与特异性,推动着磁共振成像在生物医学领域的广泛应用.本文就目前国内外热门研究的可激活磁共振纳米探针的种类、原理等方面进行阐述,详细介绍了可激活磁共振纳米探针在生物医学上的应用,在前景方面也进行了展望.     

新型吲哚七甲川菁染料HI-6的合成及光声成像评价

以2,3,3-三甲基-3H吲哚与四氢呋喃甲基溴为原料,制得季铵盐（B）; B与2-氯-3-羟次甲基环己烯醛反应合成了以呋喃环为侧链的新型吲哚七甲川菁染料（HI-6）,其结构经¹H NMR, ¹³C NMR和HR-MS(ESI)表征。以吲哚箐绿（ICG）为对照,进行了荷瘤小鼠体内/体外的光声成像评价。结果表明：HI-6的最大吸收波长为776 nm,发射波长为819 nm。 HI-6在体外和体内的光声强度均远高于ICG,且在肿瘤部位有一定聚集性。     

透明质酸纳米材料在荧光/光声成像和光疗中的应用

荧光/光声成像和光疗技术的生物医学应用引起了人们越来越多的关注, 然而很多荧光/光声造影剂存在生物相容性较差, 缺乏肿瘤靶向性, 信噪比较低, 功能单一等共性问题, 严重限制其诊疗应用. 透明质酸具有优异的生物相容性和主动肿瘤靶向性, 可被透明质酸酶降解, 并且易于化学修饰和实现多种超分子弱相互作用力协同工作. 因此, 人们将透明质酸与荧光/光声造影剂结合制备纳米材料, 使其在细胞乃至活体的标记性能和治疗效果获得了很大的改善. 本文综述了将两类物质结合制备纳米材料的方法, 着重阐述了纳米材料的结构与性能关系, 为其未来设计和开发提供了指导, 最后对存在的主要问题以及未来的重要研究方向进行了分析和展望.     

光声位相理论及其在化学中的应用研究进展

光声位相作为光声光谱重要的一部分, 包含着很多有价值的信息, 对它的研究可以获得其它光谱甚至光声振幅谱都不能得到的信息。光声位相在测定样品的光学和热学性质、样品无辐射弛豫过程的研究以及深度剖面分析等方面显示了特有的能力。本文结合本实验室近几年的工作, 在光声光谱理论的基础上,对光声位相理论及其在化学中的应用作一综述。     

半导体共轭聚合物光学探针的设计及在自发光成像和光声成像中的应用

光学成像因其无侵袭性、高时空分辨率和高灵敏度在生物医学领域得到迅速发展.光学成像中自发光成像包括化学发光成像和长余辉成像不需实时光激发,避免了自发荧光的影响,可以得到较高的灵敏度和信噪比.光声成像则是将光信号通过热膨胀转化为声信号,避免了光散射的影响,具有较高的组织穿透深度.本文针对半导体共轭聚合物光学探针在自发光成像...     

肿瘤特异性多肽探针及其在生物成像中的应用

肿瘤是由细胞、细胞外基质及微环境等多因素组成的复杂系统,不同因素在肿瘤的发生和发展中发挥关键作用.肿瘤细胞、细胞外基质及微环境的特异性分析对于肿瘤的精准诊断和靶向治疗至关重要.多肽探针具有特异性高、生物相容性好、组织穿透能力强和易于制备等优点,已被广泛用于肿瘤的特异性成像研究.本文综述了多肽探针对肿瘤细胞、免疫细胞等细胞靶点的特异性成像;并介绍了以胶原蛋白、纤维蛋白等外基质蛋白为靶点的肿瘤特异性多肽探针的成像研究.本文还总结了对肿瘤微环境中弱酸性、高酶活性等因素响应的肿瘤特异性多肽探针及其生物成像应用.最后,本文总结并讨论了肿瘤特异性多肽探针所面临的挑战与机遇,展望了其在肿瘤精准诊断和个性化治疗领域的前景.     

双联光声传感器和差分池在液体光声检测中的应用

利用双联传感器得到光声信号的叠加作用,可提高光声检测灵敏度或扣除溶液背景吸收。以亚硝基R盐测定钴为例,得到最低检测浓度为0.3ng/mL,相当于4.25×10~(-5)的吸收。     

肿瘤酸性微环境中长保留的铈基双模态成像造影剂研究

利用新型材料设计和制备高效、靶向性、多功能的诊疗一体化试剂是生物医学领域的研究热点.纳米颗粒可以通过在纳米尺度上调节特定的结构和组成来实现诸如控释、靶向、智能响应、生物相容和生物降解等多种功能的高效整合,作为多功能智能诊疗剂的集成载体提高诊疗试剂的性能和临床效果,并有望实现肿瘤的早期诊断、精确定位、原位治疗以及治疗过程...     

肿瘤诊断的MRI造影剂*

磁共振成像是临床上常用的无侵入性肿瘤早期诊断手段,常常需要借助造影剂来提高诊断能力。造影剂可缩短质子的弛豫时间,间接地改变质子所产生的信号强度并能改变体内局部组织中水质子的弛豫速率,提高正常与患病部位的成像对比度。本文较系统地评述了目前国内外用于肿瘤成像造影剂的研究进展,并讨论了顺磁性造影剂的发展前景。     

Activatable Molecular Probes for Second Near-Infrared Fluorescence,Chemiluminescence, and Photoacoustic Imaging

Optical imaging plays a crucial role in biomedicine. However, due to strong light scattering and autofluorescence in biological tissue between 650–900 nm, conventional optical imaging often has a poor signal-to-background ratio and shallow penetration depth, which limits its ability in deep-tissue in vivo imaging. Second near-infrared fluorescence, chemiluminescence, and photoacoustic imaging modalities mitigate these issues by their respective advantages of minimized light scattering, eliminated external excitation, and ultrasound detection. To enable disease detection, activatable molecular probes (AMPs) with the ability to change their second near-infrared fluorescence, chemiluminescence, or photoacoustic signals in response to a biomarker have been developed. This Minireview summarizes the molecular design strategies, sensing mechanisms, and imaging applications of AMPs. The potential challenges and perspectives of AMPs in deep-tissue imaging are also discussed.     

Activatable Molecular Probes for Second Near‐Infrared Fluorescence,Chemiluminescence, and Photoacoustic Imaging

Optical imaging plays a crucial role in biomedicine. However, due to strong light scattering and autofluorescence in biological tissue between 650–900 nm, conventional optical imaging often has a poor signal‐to‐background ratio and shallow penetration depth, which limits its ability in deep‐tissue in vivo imaging. Second near‐infrared fluorescence, chemiluminescence, and photoacoustic imaging modalities mitigate these issues by their respective advantages of minimized light scattering, eliminated external excitation, and ultrasound detection. To enable disease detection, activatable molecular probes (AMPs) with the ability to change their second near‐infrared fluorescence, chemiluminescence, or photoacoustic signals in response to a biomarker have been developed. This Minireview summarizes the molecular design strategies, sensing mechanisms, and imaging applications of AMPs. The potential challenges and perspectives of AMPs in deep‐tissue imaging are also discussed.     

An Activatable Polymeric Reporter for Near-Infrared Fluorescent and Photoacoustic Imaging of Invasive Cancer

Discriminative detection of invasive and noninvasive breast cancers is crucial for their effective treatment and prognosis. However, activatable probes able to do so in vivo are rare. Herein, we report an activatable polymeric reporter (P-Dex) that specifically turns on near-infrared (NIR) fluorescent and photoacoustic (PA) signals in response to the urokinase-type plasminogen activator (uPA) overexpressed in invasive breast cancer. P-Dex has a renal-clearable dextran backbone that is linked with a NIR dye caged with an uPA-cleavable peptide substrate. Such a molecular design allows P-Dex to passively target tumors, activate NIR fluorescence and PA signals to effectively distinguish invasive MDA-MB-231 breast cancer from noninvasive MCF-7 breast cancer, and ultimately undergo renal clearance to minimize the toxicity potential. Thus, this polymeric reporter holds great promise for the early detection of malignant breast cancer.     

An Activatable Polymeric Reporter for Near‐Infrared Fluorescent and Photoacoustic Imaging of Invasive Cancer

Discriminative detection of invasive and noninvasive breast cancers is crucial for their effective treatment and prognosis. However, activatable probes able to do so in vivo are rare. Herein, we report an activatable polymeric reporter (P‐Dex) that specifically turns on near‐infrared (NIR) fluorescent and photoacoustic (PA) signals in response to the urokinase‐type plasminogen activator (uPA) overexpressed in invasive breast cancer. P‐Dex has a renal‐clearable dextran backbone that is linked with a NIR dye caged with an uPA‐cleavable peptide substrate. Such a molecular design allows P‐Dex to passively target tumors, activate NIR fluorescence and PA signals to effectively distinguish invasive MDA‐MB‐231 breast cancer from noninvasive MCF‐7 breast cancer, and ultimately undergo renal clearance to minimize the toxicity potential. Thus, this polymeric reporter holds great promise for the early detection of malignant breast cancer.     

Activatable 19F MRI Nanoparticle Probes for the Detection of Reducing Environments

¹⁹F magnetic resonance imaging (MRI) probes that can detect biological phenomena such as cell dynamics, ion concentrations, and enzymatic activity have attracted significant attention. Although perfluorocarbon (PFC) encapsulated nanoparticles are of interest in molecular imaging owing to their high sensitivity, activatable PFC nanoparticles have not been developed. In this study, we showed for the first time that the paramagnetic relaxation enhancement (PRE) effect can efficiently decrease the ¹⁹F NMR/MRI signals of PFCs in silica nanoparticles. On the basis of the PRE effect, we developed a reduction‐responsive PFC‐encapsulated nanoparticle probe, FLAME‐SS‐Gd³⁺ (FSG). This is the first example of an activatable PFC‐encapsulated nanoparticle that can be used for in vivo imaging. Calculations revealed that the ratio of fluorine atoms to Gd³⁺ complexes per nanoparticle was more than approximately 5.0×10², resulting in the high signal augmentation.     

基于树状大分子的纳米CT成像造影剂的制备及其生物医学应用

树状大分子是一类高度支化的单分散性大分子,具有精确可控的分子结构.本文在树状大分子结构特点的基础上,阐述了以树状大分子为载体的新型纳米CT成像造影剂的合成及其在CT成像中的应用,并对树状大分子在CT成像中的发展趋势和应用领域进行了展望.     

可激活的NIR-Ⅱ探针用于肿瘤成像

波长位于1000~1700 nm之间的近红外窗口,通常被称为第二近红外(NIR-Ⅱ)窗口,在生物成像方面(荧光成像、光声成像等),该窗口展现出强大的吸引力。相比在可见光(400~700 nm)区域和第一近红外(NIR-Ⅰ,700~900 nm)窗口的传统成像,NIR-Ⅱ生物成像提供了分辨率高和穿透深度深等优点。但是,目前大多数“always-on”探针,并不能实现更高的信噪比。肿瘤微环境响应型智能药物的成像只在肿瘤中触发,可以克服这一局限性。因此,应充分结合肿瘤微环境和NIR-Ⅱ智能响应探针,充分发挥两者的优势,提高肿瘤的精准诊断。本文从不同的病理参数综述了可激活的NIR-Ⅱ荧光探针在生物成像中的最新研究进展,并对这一新兴的领域所面临的机遇和挑战提出看法。     

Molecular Photoacoustic Tomography with Colloidal Nanobeacons

Spotting clots : Vascularly constrained colloidal gold nanobeacons (GNBs; see picture) can be used as exogenous photoacoustic contrast agents for the targeted detection of fibrin, a major biochemical feature of thrombus. Fibrin‐targeted GNBs provide a more than tenfold signal enhancement in photoacoustic tomography in the near‐IR wavelength window, indicating their potential for diagnostic imaging.

     

Recent Progress on Manganese-Based Nanostructures as Responsive MRI Contrast Agents

Manganese-based nanostructured contrast agents (CAs) entered the field of medical diagnosis through magnetic resonance imaging (MRI) some years ago. Although some of these Mn-based CAs behave as classic T₁ contrast enhancers in the same way as clinical Gd-based molecules do, a new type of Mn nanomaterials have been developed to improve MRI sensitivity and potentially gather new functional information from tissues by using traditional T₁ contrast enhanced MRI. These nanomaterials have been designed to respond to biological environments, mainly to pH and redox potential variations. In many cases, the differences in signal generation in these responsive Mn-based nanostructures come from intrinsic changes in the magnetic properties of Mn cations depending on their oxidation state. In other cases, no changes in the nature of Mn take place, but rather the nanomaterial as a whole responds to the change in the environment through different mechanisms, including changes in integrity and hydration state. This review focusses on the chemistry and MR performance of these responsive Mn-based nanomaterials.